 |
|
 |
- November 20, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Presentation |
|
"Treatment with insulin detemir provides improved glycaemic control and less weight gain compared to NPH insulin in people with diabetes"Dr. A. J. Garber (biography)
English - 2004-09-09 - 23 minutes
|
 | (16 slides) |
Summary :
In this presentation Dr. Garber discusses the advantages of treatment with insulin detemir compared to NPH insulin.
Insulin detemir is a new basal insulin analogue containing a myristic acid fatty acid chain, and having three modes of protracted action. In the results of a meta-analysis of six randomised, prospective trials done in type1 and type 2 diabetic patients, detemir was associated with significantly better glycaemic control with no weight gain compared to NPH over 16 to 24 weeks of treatment.
Furthermore detemir use was associated with better predictability of glycaemic control and lower rates of minor hypoglycaemia compared to NPH insulin. Dr. Garber reviews the data from this study as they were presented at the 2004 EASD Meeting in Munich, Germany.
Copyright © 2004 E-MedHosting.com Inc.
Learning objectives :
After viewing this presentation, the participant will be able to discuss:
- The characteristics and modes of protracted action of insulin detemir
- The effects of insulin detemir compared to NPH insulin in terms of:
Glycaemic control
Day-to-day variation in fasting blood glucose levels
Change in body weight
Risk of minor hypoglycaemia
|
|
|
|
|
|
| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
| Social |
|
| |
Let others know about this presentation.
|
|
|
|
